Archive: 25/01/2019
Cystic fibrosis drug combo found safe and effective for 2- to 5-year-olds
An open label Phase 3 study conducted at Ann & Robert H. Lurie Children's Hospital of Chicago and other centers established that a combination of cystic fibrosis drugs lumacaftor and ivacaftor is safe and effective in children ...
Jan 25, 2019
'Enhanced recovery' protocol reduces opioid use in spinal surgery patients
A novel "Enhanced Recovery After Surgery" (ERAS) protocol developed by Penn Medicine for patients undergoing spinal and peripheral nerve surgery significantly reduced opioid use. A new study published in the Journal of Neurosurgery: ...
Jan 25, 2019